AMAAC

• Abstracts must be written in English.
• All abstracts are considered an E-Poster.
• Maximum number of authors: 10.
• Only 02 posters by submission will be accepted.
• Abstract body must have a 500-word count limit.
• Use standard and well-accepted abbreviations.
• Use a concise title, the title should be in sentence case (eg: Using food science to enhance STEM education).
• The submitted work must not, or will not have been: published in any journal, or on any website before 01 Novembre 2023, or presented at any national or international scientific conference prior to 01 Novembre 2023.
• Abstract content should be single-spaced and typed in lower case.
• Abstracts shall be of original research and contain a concise statement of study aim.
• Submit four (4) parts of your abstract: Background, Method, Results, and Conclusion(s). Conclusions must be supported by your results and summarized within your abstract at the time of submission. Results “to be completed” and/or conclusions “to be discussed” are not acceptable.
• Literature abstracts, and about case abstracts will not be accepted.
• The deadline will be the same as the submission deadline 01 september 2023.
• Submission only online.
Submission deadline: 01 september 2023.
The date of the acceptance or rejection response: 15 september 2023
The deadline for sending the final version of abstract: 01 October 2023.

AMAAC

First International conference for cancer In Yemen
09-11 May 2023

We are delighted to announce that REGISTRATION & CALL FOR ABSTRACTS SUBMISSION for NCI's annual congress "Bridging Gaps in Oncology, 2022" is now open!!

The conference will be held from 2 - 4 November, 2022.

For abstract submission, please follow the guidelines in the link below⬇️
http://bgo-eg.com/page/p/Abstracts

The conference program and workshops will be accredited by the American Association of Continuing Medical Education (AACME).
Registration fee is 1000 L.E. Registration is free for all NCI Staff

24th Annual Scientific Conference of ACOD
The 2nd Annual ASTRO Middle East Radiation Oncology Refresher Course in Collaboration with AMAAC

هذه الرساله تلقيتها من ا.د. احمد الزواوى
برجاء ارسال هذا للسادة الزملاء فى التخصصات المختلفة خصوصا الشباب. يبدأ هذا الكورس الدولى والمجانى يوم 18 فبراير وحتى مايو . وهو تدريب فى البحث العلمى والتجارب الاكلينكية وكيفية تمويل الابحاث والمنح وهو عن طريق الانترنت.( مجانى)

شكرا جزيلا

اللهم اجعل فى هذا نفعا وفائدة للزملاء وللمرضى والبحث العلمى وكليات الطب والصيدلة.
ا.د. احمد الزواوى
رئيس مجلس مديرى جامعة العالم للاورام
Dear Colleagues, To register to the virtual course February 18 2021 - May 2021: Certificate programs in Clinical trials and hypofractionated radiotherapy : click https://forms.gle/EaRaDqrsamXFbb4DA  Or click February 18 2021 - May 2021: Certificate programs in Clinical trials and hypofractionated radiotherapy Or Click www.ghcuniversity.org then click on academics https://www.ghcuniversity.org/academics Please feel free to forward to all who may be interested Kindest regards, Sincerely, Ahmed Prof. Ahmed Elzawawy www.icedoc.net/winwin.htm Click www.ghcuniversity.org https://www.ghcuniversity.org/academics Schedule of 2021  February 18 2021 - May 2021: Certificate programs in Clinical trials and hypofractionated radiotherapy ======================================================== From Daniel Seymour, MPA Senior Program Manager | BIO Ventures for Global Health
ine with BVGH's programs the African Access Initiative (AAI) and the African Consortium for Cancer Clinical Trials (AC3T), It is my pleasure to extend an invitation to you and your colleagues to attend the AAI Virtual Training Series for Cancer Clinical Trials.  The AAI Virtual Training Series for Cancer Clinical Trials is designed to build clinical oncology research capacity and to accomplish the overlapping goals of AC3T and the Africa-OxfordHarvard Initiative (AfrOx-H). This 14-week online course has been designed with input from leaders at participating AC3T sites and will prepare your institution to conduct cancer clinical trials at international standards.  Attendance will be open first to AfrOx-H and AC3T partner sites across sub-Saharan Africa. The target audience for this program are oncologists, practicing physicians, and faculty members who are currently engaged as or would like to be principal investigators. Participants who complete the full course will be eligible to receive continuing medical education credits and a certificate of course completion issued by BVGH and AfrOx-H. The course will be held virtually via Zoom and Google Classroom and will begin on February 18, 2021.  The course will cover the following topics as they relate to cancer clinical trials: - Drug development process - Clinical trials basics - Phase I, II, III, and IV clinical trials - Good clinical practice - Protocol design and statistical methods - Research ethics - Patient recruitment - Cross-sector perspectives and practices - Budgeting for clinical trials - Imaging in oncology trials - Patient communication - Writing competitive grant applications To register, please use the following link: https://forms.gle/EaRaDqrsamXFbb4DA Please feel free to share the attached program announcement with interested parties. We appreciate your partnership and look forward to working with you in this course. Kind regards, Daniel Daniel Seymour, MPA Senior Program Manager | BIO Ventures for Global Health

AAI Virtual Training Series for Cancer Clinical Trials BIO Ventures for Global Health (BVGH) and the Africa-Oxford-Harvard Initiative (AfrOx-H) are proud to announce the upcoming AAI Virtual Training Series for Cancer Clinical Trials. This training program is offered under the purview of AAI and the African Consortium for Cancer Clinical Trials (AC3T).....

يمكنك الان متابعة كل المؤتمرات الطبية الخاصة بالاورام على موقع الرابطة
www.amaac.org/calendar
يتم اضاقة المؤتمرات بمجرد وصولها لنا - ارسل لنا مؤتمرك أو دورات تدريبية ليستفيد بها الاطباء العرب